Sat, Nov 22, 2014, 9:39 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • gjjlrj gjjlrj Dec 29, 2006 4:32 PM Flag

    Merck & Co. Closes Sirna Acquisition


    Friday December 29, 1:28 pm ET
    Merck Closes $1.1 Billion Cash Acquisition of Sirna Therapeutics After Shareholder Vote

    WHITEHOUSE STATION, N.J. (AP) -- Drug maker Merck & Co. said Friday it closed its $1.1 billion cash acquisition of the tiny biotech drug developer Sirna Therapeutics Inc. after shareholders approved the deal.
    Late Thursday, Sirna shareholders voted to approve Merck's $13 per share offer, more than double the company's share price just before the offer was made in late October.

    Merck offered to buy the San Francisco-based company for its RNA interference technology, a Nobel Prize-winning technique where genes responsible for diseases are "silenced" by messenger-carrying RNA.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
15.73-0.05(-0.32%)Nov 21 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Hexcel Corp.
NYSEFri, Nov 21, 2014 4:02 PM EST
Celgene Corporation
NasdaqGSFri, Nov 21, 2014 4:00 PM EST
BHP Billiton plc
NYSEFri, Nov 21, 2014 4:02 PM EST